These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 24935619)
1. Bayesian hierarchical model for multiple repeated measures and survival data: an application to Parkinson's disease. Luo S; Wang J Stat Med; 2014 Oct; 33(24):4279-91. PubMed ID: 24935619 [TBL] [Abstract][Full Text] [Related]
2. A Bayesian approach to joint analysis of multivariate longitudinal data and parametric accelerated failure time. Luo S Stat Med; 2014 Feb; 33(4):580-94. PubMed ID: 24009073 [TBL] [Abstract][Full Text] [Related]
3. Joint modeling of multivariate longitudinal measurements and survival data with applications to Parkinson's disease. He B; Luo S Stat Methods Med Res; 2016 Aug; 25(4):1346-58. PubMed ID: 23592717 [TBL] [Abstract][Full Text] [Related]
4. Robust Bayesian hierarchical model using normal/independent distributions. Chen G; Luo S Biom J; 2016 Jul; 58(4):831-51. PubMed ID: 26711558 [TBL] [Abstract][Full Text] [Related]
5. Robust Bayesian inference for multivariate longitudinal data by using normal/independent distributions. Luo S; Ma J; Kieburtz KD Stat Med; 2013 Sep; 32(22):3812-28. PubMed ID: 23494809 [TBL] [Abstract][Full Text] [Related]
6. Bayesian multiple imputation for missing multivariate longitudinal data from a Parkinson's disease clinical trial. Luo S; Lawson AB; He B; Elm JJ; Tilley BC Stat Methods Med Res; 2016 Apr; 25(2):821-37. PubMed ID: 23242384 [TBL] [Abstract][Full Text] [Related]
7. Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial. Shoulson I; Oakes D; Fahn S; Lang A; Langston JW; LeWitt P; Olanow CW; Penney JB; Tanner C; Kieburtz K; Rudolph A; Ann Neurol; 2002 May; 51(5):604-12. PubMed ID: 12112107 [TBL] [Abstract][Full Text] [Related]
8. Multidimensional latent trait linear mixed model: an application in clinical studies with multivariate longitudinal outcomes. Wang J; Luo S Stat Med; 2017 Sep; 36(20):3244-3256. PubMed ID: 28569393 [TBL] [Abstract][Full Text] [Related]
9. Bayesian multivariate augmented Beta rectangular regression models for patient-reported outcomes and survival data. Wang J; Luo S Stat Methods Med Res; 2017 Aug; 26(4):1684-1699. PubMed ID: 26037528 [TBL] [Abstract][Full Text] [Related]
10. Novel non-linear models for clinical trial analysis with longitudinal data: A tutorial using SAS for both frequentist and Bayesian methods. Wang G; Wang W; Mangal B; Liao Y; Schneider L; Li Y; Xiong C; McDade E; Kennedy R; Bateman R; Cutter G Stat Med; 2024 Jul; 43(15):2987-3004. PubMed ID: 38727205 [TBL] [Abstract][Full Text] [Related]
11. Deprenyl and tocopherol antioxidative therapy of parkinsonism (DATATOP). Parkinson Study Group. Shoulson I Acta Neurol Scand Suppl; 1989; 126():171-5. PubMed ID: 2515723 [TBL] [Abstract][Full Text] [Related]
12. Effect of deprenyl on the progression of disability in early Parkinson's disease. Parkinson Study Group N Engl J Med; 1989 Nov; 321(20):1364-71. PubMed ID: 2509910 [TBL] [Abstract][Full Text] [Related]
13. Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort. Marras C; McDermott MP; Rochon PA; Tanner CM; Naglie G; Rudolph A; Lang AE; Neurology; 2005 Jan; 64(1):87-93. PubMed ID: 15642909 [TBL] [Abstract][Full Text] [Related]
14. Semiparametric multivariate joint model for skewed-longitudinal and survival data: A Bayesian approach. Chen J; Huang Y; Wang Q Stat Med; 2023 Nov; 42(27):4972-4989. PubMed ID: 37668072 [TBL] [Abstract][Full Text] [Related]
15. DATATOP: a decade of neuroprotective inquiry. Parkinson Study Group. Deprenyl And Tocopherol Antioxidative Therapy Of Parkinsonism. Shoulson I Ann Neurol; 1998 Sep; 44(3 Suppl 1):S160-6. PubMed ID: 9749589 [TBL] [Abstract][Full Text] [Related]
16. DATATOP: a multicenter controlled clinical trial in early Parkinson's disease. Parkinson Study Group. Arch Neurol; 1989 Oct; 46(10):1052-60. PubMed ID: 2508608 [TBL] [Abstract][Full Text] [Related]
17. Bayesian joint models for multi-regional clinical trials. Bean NW; Ibrahim JG; Psioda MA Biostatistics; 2024 Jul; 25(3):852-866. PubMed ID: 37669215 [TBL] [Abstract][Full Text] [Related]
18. Bayesian Hierarchical Joint Modeling Using Skew-Normal/Independent Distributions. Chen G; Luo S Commun Stat Simul Comput; 2018; 47(5):1420-1438. PubMed ID: 30174369 [TBL] [Abstract][Full Text] [Related]
19. Clinical trials of neuroprotection in Parkinson's disease: long-term selegiline and alpha-tocopherol treatment. LeWitt PA J Neural Transm Suppl; 1994; 43():171-81. PubMed ID: 7884399 [TBL] [Abstract][Full Text] [Related]
20. A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts. Marras C; Lang AE; Eberly SW; Oakes D; Fahn S; Schwid SR; Hyson C; Shoulson I; Mov Disord; 2009 Dec; 24(16):2370-8. PubMed ID: 19908310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]